二、申请人信息 三、临床试验信息 1、试验目的 通过BICR评估,确定携带NTRK1/2/3、ROS1或ALK基因重排的每类实体瘤患者人群(篮子)接受Entrectinib治疗后的客观缓解率(ORR) 2、试验设计 3、受试者信息 4、试验分组 5、终点指标 6、数据安全监查委员会(DMC) 无 7、为受试者购买试验伤害保险 有 四、研究者信...
Editorial acknowledgement Michael Sheldon, PhD, of Scion, London, UK, funded by Bayer. Legal entity responsible for the study Bayer. Funding Bayer. Disclosure X. Jiao: Full / Part-time employment: Bayer. A. Lokker: Full / Part-time employment: Flatiron Health; Shareholder / Stockholder / ...
American Beacon The London Company Income Equity Fund Inv-0.09% AMGIX $37.65 American Century Disciplined Core Value Fund Inst-0.15% AAVVF $6.83 Advantage Energy Ltd.+0.04% NQSSPH $1,467.01 NASDAQ US Smart Pharmaceuticals Index+13.12% NWC:CA $45.67 The North...
1 MMaarriittiimmeeKKnnoowwlleeddggeeCCeennttrree IMOTHESAURUS Revised:July2010 4AlbertEmbankment,LondonSE17SR,UnitedKingdom. Tel:+442077357611,http://.imoEmailMaritimeKnowledgeCentre@imo 2 ABANDONMENT BTOffshoreinstallations ABANDONMENTOF SEAFARERS ...
Wendy B. LondonGarrett M. BrodeurotherLight JE, Koyama H, Minturn JE, et al. Clinical significance of NTRK family gene expression in neuroblastomas. Pediatr Blood Cancer. 2012;59(2):226–32.Light JE, Koyama H, Minturn JE, Ho R, Simpson AM, Iyer R, et al. Clinical significance of ...